Literature DB >> 21862776

Small serotonin-producing neuroendocrine tumor of the pancreas associated with pancreatic duct obstruction.

Satomi Kawamoto1, Chanjuan Shi, Ralph H Hruban, Michael A Choti, Richard D Schulick, Elliot K Fishman, Stanley S Siegelman.   

Abstract

OBJECTIVE: Pancreatic neuroendocrine tumors expressing serotonin (carcinoid tumors) account for a small portion of pancreatic neuroendocrine tumors. The purpose of this study was to describe cases of small serotonin-producing pancreatic neuroendocrine tumors associated with pancreatic duct obstruction.
CONCLUSION: Serotonin produced by pancreatic neuroendocrine tumors can induce fibrosis and pancreatic duct obstruction. Pancreatic neuroendocrine tumors should be considered when CT shows a small hypervascular mass associated with upstream pancreatic duct dilatation or atrophy. Evidence of small pancreatic neuroendocrine tumors should be sought in cases of idiopathic pancreatic duct stenosis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21862776     DOI: 10.2214/AJR.10.5428

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  12 in total

1.  Whipple made simple for surgical pathologists: orientation, dissection, and sampling of pancreaticoduodenectomy specimens for a more practical and accurate evaluation of pancreatic, distal common bile duct, and ampullary tumors.

Authors:  N Volkan Adsay; Olca Basturk; Burcu Saka; Pelin Bagci; Denizhan Ozdemir; Serdar Balci; Juan M Sarmiento; David A Kooby; Charles Staley; Shishir K Maithel; Rhonda Everett; Jeanette D Cheng; Duangpeng Thirabanjasak; Donald W Weaver
Journal:  Am J Surg Pathol       Date:  2014-04       Impact factor: 6.394

2.  Pathologic Evaluation and Reporting of Intraductal Papillary Mucinous Neoplasms of the Pancreas and Other Tumoral Intraepithelial Neoplasms of Pancreatobiliary Tract: Recommendations of Verona Consensus Meeting.

Authors:  Volkan Adsay; Mari Mino-Kenudson; Toru Furukawa; Olca Basturk; Giuseppe Zamboni; Giovanni Marchegiani; Claudio Bassi; Roberto Salvia; Giuseppe Malleo; Salvatore Paiella; Christopher L Wolfgang; Hanno Matthaei; G Johan Offerhaus; Mustapha Adham; Marco J Bruno; Michelle D Reid; Alyssa Krasinskas; Günter Klöppel; Nobuyuki Ohike; Takuma Tajiri; Kee-Taek Jang; Juan Carlos Roa; Peter Allen; Carlos Fernández-del Castillo; Jin-Young Jang; David S Klimstra; Ralph H Hruban
Journal:  Ann Surg       Date:  2016-01       Impact factor: 12.969

Review 3.  Pancreatic neuroendocrine neoplasms: Clinicopathological features and pathological staging.

Authors:  Alfred King-Yin Lam; Hirotaka Ishida
Journal:  Histol Histopathol       Date:  2020-12-11       Impact factor: 2.303

4.  Serotonin expression in pancreatic neuroendocrine tumors correlates with a trabecular histologic pattern and large duct involvement.

Authors:  Chad M McCall; Chanjuan Shi; Alison P Klein; Björn Konukiewitz; Barish H Edil; Trevor A Ellison; Christopher L Wolfgang; Richard D Schulick; Günter Klöppel; Ralph H Hruban
Journal:  Hum Pathol       Date:  2012-01-04       Impact factor: 3.466

Review 5.  New frontiers in imaging including radiomics updates for pancreatic neuroendocrine neoplasms.

Authors:  Mohammed Saleh; Priya R Bhosale; Motoyo Yano; Malak Itani; Ahmed K Elsayes; Daniel Halperin; Emily K Bergsland; Ajaykumar C Morani
Journal:  Abdom Radiol (NY)       Date:  2020-10-23

6.  Expression of CD24, a Stem Cell Marker, in Pancreatic and Small Intestinal Neuroendocrine Tumors.

Authors:  Safia Salaria; Anna Means; Frank Revetta; Kamran Idrees; Eric Liu; Chanjuan Shi
Journal:  Am J Clin Pathol       Date:  2015-10       Impact factor: 2.493

7.  National Rise of Primary Pancreatic Carcinoid Tumors: Comparison to Functional and Nonfunctional Pancreatic Neuroendocrine Tumors.

Authors:  Gyulnara G Kasumova; Omidreza Tabatabaie; Mariam F Eskander; Abhishek Tadikonda; Sing Chau Ng; Jennifer F Tseng
Journal:  J Am Coll Surg       Date:  2016-12-10       Impact factor: 6.113

8.  Neuroendocrine carcinoma of the pancreas with similar genetic alterations to invasive ductal adenocarcinoma.

Authors:  Tetsuo Kimura; Hiroshi Miyamoto; Akira Fukuya; Shinji Kitamura; Koichi Okamoto; Masako Kimura; Naoki Muguruma; Tetsuya Ikemoto; Mitsuo Shimada; Akiko Yoneda; Yoshimi Bando; Makoto Takishita; Tetsuji Takayama
Journal:  Clin J Gastroenterol       Date:  2016-06-04

9.  Cadherin 17 is frequently expressed by 'sclerosing variant' pancreatic neuroendocrine tumour.

Authors:  Adam Johnson; Jesse P Wright; Zhiguo Zhao; Tatsuki Komaya; Alexander Parikh; Nipun Merchant; Chanjuan Shi
Journal:  Histopathology       Date:  2014-10-28       Impact factor: 5.087

10.  Intratumoral Fibrosis and Tumor Growth Pattern as Prognostic Factors in Optimally Resected Pancreatic Neuroendocrine Neoplasms: An Analysis of 168 Cases.

Authors:  Deyali Chatterjee; Nikolaos A Trikalinos; Greg A Williams; Jingxia Liu; William G Hawkins; Chet Hammill
Journal:  Pancreas       Date:  2020-02       Impact factor: 3.243

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.